Product Information
ZENPEP DR 3,000 UNIT CAPSULE is a brand product labeled by Aimmune Therapeutics, Inc., priced at $2.2145 per EA under NDC 73562011301. Its NADAC has been published 252 times since Dec 8, 2021.
ZENPEP DR 3,000 UNIT CAPSULE
pancrelipase lipase, pancrelipase protease, pancrelipase amylaseStrength
14000; 3000; 10000 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Aimmune Therapeutics, Inc.NDC
73562011301
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022210On Market Since
1/1/2021
Price Statistics
The NADAC for ZENPEP DR 3,000 UNIT CAPSULE has been published 252 times since Dec 8, 2021, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2145 per EA |
|---|---|
| All-time high | $2.2197 (May 13, 2026) |
| All-time low | $1.9172 (Dec 8, 2021) |
| 52-week high | $2.2197 |
| 52-week low | $2.1339 |
| Median price | $2.0742 |
| Average price | $2.0685 |
| Largest weekly change | +4.0% (Jan 4, 2023) |
| Weeks tracked | 252 |
| Tracking since | Dec 8, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pancrelipase lipase, pancrelipase protease, pancrelipase amylase market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aimmune Therapeutics, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pancrelipase lipase, pancrelipase protease, pancrelipase amylase market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZENPEP DR 3,000 UNIT CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZENPEP DR 3,000 UNIT CAPSULE, manufactured by Aimmune Therapeutics, Inc., is $2.2145 per EA (NDC 73562011301), effective Sep 30, 2026.
How has the price of ZENPEP DR 3,000 UNIT CAPSULE changed over time?
Over the history we have for it, the NADAC for ZENPEP DR 3,000 UNIT CAPSULE has risen 15.5%. It has been tracked across 252 weekly CMS publications since Dec 8, 2021.
What are the highest and lowest recorded NADAC prices for ZENPEP DR 3,000 UNIT CAPSULE?
Since Dec 8, 2021, the NADAC for ZENPEP DR 3,000 UNIT CAPSULE has ranged from a low of $1.9172 (Dec 8, 2021) to a high of $2.2197 (May 13, 2026), with a median of $2.0742 per EA.
Are there cheaper alternatives to ZENPEP DR 3,000 UNIT CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ZENPEP DR 3,000 UNIT CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZENPEP DR 3,000 UNIT CAPSULE?
ZENPEP DR 3,000 UNIT CAPSULE (NDC 73562011301) is labeled by Aimmune Therapeutics, Inc., and CMS classifies it as a brand product.